First Parkinson’s patient dosed with USP30 inhibitor

Coverage, in order

1. 14d ago
   
   Longevity.Technology UK indie

   First Parkinson’s patient dosed with USP30 inhibitor

   Mission Therapeutics has begun a 36-patient Phase 1b study of MTX325, a drug aimed at clearing out damaged mitochondria in the brain. Every cell in your body runs on mitochondria, tiny power plants that wear out like any other machinery. Cells have a cleanup routine for the broken ones. A British…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.